CausalSentinel

Protein Dossier — LGALS3 (Galectin-3)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: R07 Pain in throat and chest 0.00409 0.00108 1.56e-04 Inverse variance weighted 3 cis NA
Diagnoses - main ICD10: R07 Pain in throat and chest 0.00409 0.00108 1.56e-04 Inverse variance weighted 3 trans NA
Diagnoses - main ICD10: R07 Pain in throat and chest 0.00409 0.00108 1.56e-04 Inverse variance weighted 3 trans NA
Body mass index (BMI) 0.0152 0.00494 0.00202 Inverse variance weighted 3 cis NA
Body mass index (BMI) 0.0152 0.00494 0.00202 Inverse variance weighted 3 trans NA
Body mass index (BMI) 0.0152 0.00494 0.00202 Inverse variance weighted 3 trans NA
Ulcerative colitis 0.293 0.0956 0.00218 Wald ratio 1 trans NA
Pulse rate 0.0248 0.00866 0.00417 Inverse variance weighted 3 cis NA
Pulse rate 0.0248 0.00866 0.00417 Inverse variance weighted 3 trans NA
Pulse rate 0.0248 0.00866 0.00417 Inverse variance weighted 3 trans NA
Diagnoses - main ICD10: M17 Gonarthrosis [arthrosis of knee] 0.00213 0.000764 0.00533 Inverse variance weighted 3 cis NA
Diagnoses - main ICD10: M17 Gonarthrosis [arthrosis of knee] 0.00213 0.000764 0.00533 Inverse variance weighted 3 trans NA
…and 281 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3066_12_1 Galectin-3 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

28 association rows across 16 traits (26 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating LGALS3 levels 8e-2158 rs2075601 3 GCST90859927 no MR -> candidate analysis
LGALS3 protein levels 5e-278 rs78001930 8 GCST90469761 no MR -> candidate analysis
Galectin-3 levels 3e-272 rs76424323 4 GCST90247671 no MR -> candidate analysis
Protein biomarker 2e-188 rs2274273 1 GCST001711 no MR -> candidate analysis
Serum levels of protein LGALS3 8e-84 rs112796738 1 GCST90088218 no MR -> candidate analysis
Blood protein levels 3e-45 rs76426991 1 GCST006585 no MR -> candidate analysis
DAAM1 protein levels 4e-13 rs7160523 1 GCST90468941 no MR -> candidate analysis
Red cell distribution width 8e-11 rs8012156 1 GCST90002404 no MR -> candidate analysis
Triglycerides to total lipids ratio in chylomicrons and extr 2e-9 rs750614951 1 GCST90093051 no MR -> candidate analysis
Galectin 3 plasma levels 1e-8 rs6573005 1 GCST90085736 no MR -> candidate analysis
Cholesteryl esters to total lipids ratio in chylomicrons and 2e-8 rs750614951 1 GCST90093043 no MR -> candidate analysis
T-cell surface glycoprotein CD3 epsilon chain protein levels 2e-8 rs112756125 1 GCST90443215 no MR -> candidate analysis
…and 4 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 2160 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Hypercholesterolemia 0.365 common-variant locus MR: beta=0.00759, p=0.308 (cis)
osteoarthritis 0.263 common-variant locus MR: beta=0.0935, p=0.124 (cis)
arthropathy 0.256 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 1 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 3 known modulators (Galectin-3)
gnomAD constraint pLI=3.1e-06, LOEUF=1.29 — LoF-tolerant
GWAS Catalog 42 unique SNPs / 82 rows
ClinVar 73 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance